| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| SNY | Sanofi | $43.75 | $109.14B | Downtrend |
The 7 Most Expensive Prescription Drugs in the World
https://www.fool.com/investing/2017/04/18/the-7-most-expensive-prescription-drugs-in-the-wor.aspx?source=iedfolrf0000001
Apr 18, 2017 - The costs of these drugs are astronomical -- from $543,000 per year to more than $1 million per year.
1.1K
Another Williams Takes His Turn Before the Camera, at SNY
https://www.nytimes.com/2017/07/20/business/doug-brian-williams-sny.html?partner=rss&emc=rss
Jul 21, 2017 - Doug Williams, a sportscaster, acknowledges he is not as well known as his father, Brian, or sister, Allison. “I enjoy being the ‘other one,’” he says.
554
Drug Shortages Push Up Prices of Similar Drugs
https://www.wsj.com/articles/prescription-drug-shortages-help-push-up-prices-of-similar-drugs-1492030801?mod=pls_whats_news_us_business_f
Apr 12, 2017 - Prescription-drug supply shortages have hurt U.S. medical care in recent years. According to new research, they’ve also caused another side effect—drug-price increases.
235
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
https://www.fool.com/investing/2017/06/30/the-9-best-selling-prescription-drugs-in-2016-each.aspx?source=iedfolrf0000001
Jun 30, 2017 - These prescription drugs raked in billions of dollars last year. But several of them might not be so lucrative for much longer.
151
Alnylam Pharmaceuticals, Inc. Stock Perked Up 14% in June -- Here's Why
https://www.fool.com/investing/2017/07/07/alnylam-pharmaceuticals-inc-stock-perked-up-14-in.aspx?source=iedfolrf0000001
Jul 07, 2017 - A new breakthrough designation and insider purchases helped Alnylam stock continue its terrific climb this year.
25
3 High-Yield Dividend Aristocrat Stocks
https://www.fool.com/investing/2017/08/28/3-high-yield-dividend-aristocrat-stocks.aspx?source=iedfolrf0000001
Aug 28, 2017 - These three high-yield dividend stocks may be worth checking out right now.
23
Here's the Best Dividend Stock in Big Pharma
https://www.fool.com/investing/2017/09/03/heres-the-best-dividend-stock-in-big-pharma.aspx?source=iedfolrf0000001
Sep 03, 2017 - There are plenty of good dividend stocks in big pharma, but AbbVie appears to be the best of all.
21
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain
https://www.fool.com/investing/2017/04/17/lilly-and-incytes-loss-is-abbvie-and-regenerons-ga.aspx?source=iedfolrf0000001
Apr 17, 2017 - The FDA has rejected Eli Lilly and Incyte's application for approval of a potential blockbuster rheumatoid arthritis drug.
16
These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop?
https://www.fool.com/investing/2017/05/22/these-3-biotech-stocks-have-ballooned-in-2017-but.aspx?source=iedfolrf0000001
May 22, 2017 - It's been a pretty good year for biotech, but these three stocks are outperforming their industry peers. Can they keep it up?
15
3 Healthcare Stocks to Buy With Dividends Yielding More Than 3%
https://www.fool.com/investing/2017/08/29/3-healthcare-stocks-to-buy-with-dividends-yielding.aspx?source=iedfolrf0000001
Aug 29, 2017 - Why AbbVie, Pfizer, and Sanofi are three of the top high-yield healthcare stocks to be found.
9
Page 1>